Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
BONE BIOLOGICS Aktie jetzt für 0€ handeln | |||||
27.06. | Bone Biologics Prices $5 Mln Public Offering With Warrants At $4 Per Share | 1 | RTTNews | ||
27.06. | Why Is Bone Biologics Stock Surging On Friday? | 4 | Benzinga.com | ||
27.06. | Bone Biologics prices $5M public offering with warrants; shares up 45% | 1 | Seeking Alpha | ||
27.06. | Why Bone Biologics Is Rising In Pre-market? | 2 | RTTNews | ||
26.06. | Bone Biologics Corp - 8-K, Current Report | 1 | SEC Filings | ||
26.06. | Bone Biologics regains Nasdaq compliance with minimum bid price rule; shares down | 1 | Seeking Alpha | ||
24.06. | Bone Biologics files $35M mixed shelf offering | 7 | Seeking Alpha | ||
24.06. | Bone Biologics Corp - S-1, General form for registration of securities | 2 | SEC Filings | ||
06.06. | Bone Biologics plunges after announcing 1-for-6 reverse stock split | 2 | Seeking Alpha | ||
06.06. | Bone Biologics kündigt Aktienzusammenlegung im Verhältnis 1:6 an | 2 | Investing.com Deutsch | ||
06.06. | Bone Biologics announces 1-for-6 reverse stock split | 1 | Investing.com | ||
06.06. | Bone Biologics Corporation Announces 1-for-6 Reverse Stock Split | 889 | Business Wire | TYSONS CORNER, Va.--(BUSINESS WIRE)--Strategy (Nasdaq: MSTR/STRK/STRF) today announced the pricing of its initial public offering on June 5, 2025 of 11,764,700 shares of 10.00% Series A Perpetual Stride... ► Artikel lesen | |
30.05. | Aktionäre von Bone Biologics genehmigen wichtige Vorschläge | - | Investing.com Deutsch | ||
30.05. | Bone Biologics Corp - 8-K, Current Report | 1 | SEC Filings | ||
12.05. | Bone Biologics Corp - 10-Q, Quarterly Report | 2 | SEC Filings | ||
01.04. | Bone Biologics Corp - 8-K, Current Report | 1 | SEC Filings | ||
26.02. | Bone Biologics Corp - 10-K, Annual Report | 1 | SEC Filings | ||
01.08.24 | Pre-market Movers: Bone Biologics, Immuneering, ALX Oncology, CareDx, MediaAlpha | 771 | AFX News | BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 07.40 A.M. ET).In the Green Bone Biologics Corporation (BBLG) is up over 61%... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SERNOVA BIOTHERAPEUTICS | 0,104 | -3,70 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes | LONDON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics ("Sernova") (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH) today announced a Collaborative Research Agreement with Eledon Pharmaceuticals... ► Artikel lesen | |
ATOSSA THERAPEUTICS | 0,720 | -0,83 % | Atossa Therapeutics, Inc.: Join Atossa Therapeutics' Exclusive Live Investor Webinar and Q&A Session on May 22 | SEATTLE, WASHINGTON / ACCESS Newswire / May 20, 2025 / Atossa Therapeutics, Inc. (Nasdaq:ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines... ► Artikel lesen | |
PING AN HEALTHCARE | 1,031 | -1,90 % | Ping An Healthcare and Technology Company Limited: Ping An Good Doctor Revamps Brand and Launches Annual Healthcare Service Brand | HONG KONG and SHANGHAI, June 11, 2025 /PRNewswire/ -- The Ping An Good Doctor Brand Revamp & Ping An Healthcare Services Brand Launch Conference was held in Shanghai. Ping An Healthcare and... ► Artikel lesen | |
CO-DIAGNOSTICS | 0,244 | -0,81 % | Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results | SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the... ► Artikel lesen | |
CYTOSORBENTS | 0,921 | +4,54 % | A Glimpse Into The Expert Outlook On CytoSorbents Through 5 Analysts | ||
VERU | 0,522 | +4,76 % | Veru Inc.: Veru Reports Positive Results from Phase 2b QUALITY and Maintenance Extension Study Showing Enobosarm Significantly Reduced Body Weight Regain, Prevented Fat Regain, and Preserved Lean Mass After Semaglutide Discontinuation | --During the Maintenance Period of 12 weeks after discontinuing semaglutide (GLP-1 receptor agonist), placebo group regained 43% of body weight that was previously lost during Phase 2b QUALITY study... ► Artikel lesen | |
TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Receives Clearance to Proceed with Pivotal Trial of Amezalpat Combination Therapy for First-Line HCC in China | Builds on clearances already received by FDA and EMAChina has the largest population of patients with hepatocellular carcinoma in the world BRISBANE, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- Tempest... ► Artikel lesen | |
VOLITIONRX | 0,770 | +13,30 % | VolitionRx - Nu.Q advances in lung cancer management | Despite rapid advancements in cancer treatments, effective diagnostics for early screening and disease monitoring continue to be an unmet need. This is felt acutely in lung cancer, which is the leading... ► Artikel lesen | |
EKSO BIONICS | 3,960 | 0,00 % | Ekso Bionics Holdings, Inc.: Virtual eksoUniversity to Support Continuing Education of PTs and PTAs Across the Country | ||
IMUNON | 0,490 | +2,51 % | Imunon, Inc.: IMUNON Granted Continued Listing Extension by Nasdaq to Complete Compliance Plan | Management provides Nasdaq Hearing Panel with a comprehensive executable plan for long term compliance LAWRENCEVILLE, N.J., July 15, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage... ► Artikel lesen | |
BEYOND AIR | 2,500 | 0,00 % | Beyond Air stock initiated with Buy rating at D. Boral Capital on LungFit platform | ||
AVINGER | 0,465 | -22,17 % | NSE - Avinger Inc - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
NOVACYT | 0,464 | +4,39 % | Novacyt S.A. - Launch of LightBench® Discover | ||
AROVELLA THERAPEUTICS | 0,071 | +11,90 % | AROVELLA THERAPEUTICS LIMITED: Notification regarding unquoted securities - ALA | ||
FRESENIUS | 41,120 | +0,88 % | Aktie von Fresenius SE & Co. KGaA heute am Aktienmarkt kaum gefragt: Kurs fällt (41,21 €) | An der deutschen Börse notiert die Fresenius SE & Co. KGaA-Aktie derzeit ein wenig leichter. Die Aktie notiert zur Stunde bei 41,21 Euro. Der Anteilsschein von Fresenius+Co KgaA verzeichnet aktuell... ► Artikel lesen |